文献速递颈动脉与弓上血管

症状性患者经股动脉颈动脉支架置入术与颈动脉内膜切除术的短期结局:来自巴西多中心前瞻性登记研究的数据

Short-Term Outcomes of Transfemoral Carotid Artery Stenting and Carotid Endarterectomy in Symptomatic Patients: Data from a Multicentric Prospective Registry in Brazil.
PubMed 文献 · Ann Vasc Surg · 2022-05-16

该研究基于巴西5所公立大学医院的前瞻性多中心登记(RHEUNI),纳入2012年1月至2019年12月的376例症状性颈动脉粥样硬化性疾病患者,比较经股动脉颈动脉支架置入术(TF-CAS)与颈动脉内膜切除术(CEA)的30天结局。结果显示两组死亡、卒中、心肌梗死及主要不良心血管事件(MACE)发生率均无统计学显著差异。

要点

  • TF-CAS组与CEA组30天死亡、卒中、心肌梗死及MACE发生率均无统计学显著差异。
  • 共纳入376例症状性患者,其中TF-CAS 152例(40.4%)、CEA 224例(59.5%),均完成30天随访。
  • 研究为前瞻性多中心观察性登记,术式选择由各术者依据术前风险评估自行决定。

核心结论

  • 在巴西5所大学医院的前瞻性登记中,症状性患者TF-CAS与CEA的30天围手术期死亡、卒中、心肌梗死及其复合结局发生率相似。

研究设计与样本

  • 前瞻性8年观察性研究,纳入2012年1月至2019年12月在巴西5所与RHEUNI关联的公立大学医院接受TF-CAS或CEA的症状性颈动脉粥样硬化性疾病患者,连续纳入所有手术,共376例(TF-CAS 152例、CEA 224例),均完成30天随访;术式选择由各术者依据术前风险评估自行决定;研究注册号NCT02538276。

主要发现

  • 死亡:TF-CAS组0.66% vs CEA组0.66%(P=0.99)。
  • 卒中:TF-CAS组4.61% vs CEA组4.46%(P=0.99)。
  • 心肌梗死:TF-CAS组0.66% vs CEA组0%(P=0.403)。
  • MACE:TF-CAS组5.92% vs CEA组4.46%(P=0.633)。
  • 上述结局在两组间均无统计学显著差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Transfemoral carotid artery stenting (TF-CAS) and carotid endarterectomy (CEA) are alternative strategies for stroke prevention in patients with atherosclerotic carotid disease. Because their main objective is to prevent future ischemic events, regular reassessment of the outcomes is mandatory for providing the best therapy. The purpose of this study was to describe the practice and the outcomes of TF-CAS and CEA in symptomatic patients in public university hospitals in Brazil, using data from a prospective multicentric registry. METHODS: A prospective 8-year observational study of patients with symptomatic carotid artery atherosclerotic disease that underwent TF-CAS and CEA in 5 public university hospitals affiliated with the RHEUNI (Registry Project of Vascular Disease in the Public University Hospitals of São Paulo). All consecutive procedures were included. The indications for the procedures were determined by each surgeon's individual discretion, in accordance with a preoperative risk evaluation. The outcome measures were any 30-day follow-up death, stroke, myocardial infarction (MI), and their combined outcome (major adverse cardiovascular events [MACE]). The registration of the study was made at clinicaltrials.gov NCT02538276. RESULTS: From January 2012 through December 2019, 376 consecutive and symptomatic patients were included in the study records. There were 152 TF-CAS procedures (40.4%) and 224 CEA procedures (59.5%). All completed the 30-day follow-up period. Occurrence of death (TF-CAS: 0.66% × CEA: 0.66%, P = 0.99), stroke (TF-CAS: 4.61% × CEA: 4.46%, P = 0.99), and MI (TF-CAS: 0.66% × CEA: 0%, P = 0.403) were similar in both groups, without statistically significant differences. MACE rate did not differ in both groups (TF-CAS: 5.92% × CEA: 4.46%, P = 0.633). CONCLUSIONS: Data from a prospective registry of 5 Brazilian university hospitals showed that TF-CAS and CEA in symptomatic patients had similar 30-day perioperative rates of death, stroke, and MI and their combination.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Joviliano EE, Ribeiro MS, Sobreira ML, et al. Short-Term Outcomes of Transfemoral Carotid Artery Stenting and Carotid Endarterectomy in Symptomatic Patients: Data from a Multicentric Prospective Registry in Brazil. Ann Vasc Surg. 2022. PMID: 35589029. doi:10.1016/j.avsg.2022.04.053

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。